Welspun Corp Ltd (WELCORP) Q1 FY27 Results Analysis: Margin Expands 352 bps, Normalized PAT Surges 62%

CompoundingAI Research Updated July 24, 2026 2 min read
Positive

Welspun Corp Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 4,081.12 Cr (+14.91% YoY) and PAT growth of +200.11% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 24, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 4,081.12 Cr (+14.91% YoY)
PAT (Q1)Rs. 1,047.88 Cr (+200.11% YoY)
EBITDA margin16.96% (+218 bps YoY)
EPS (Q1)Rs. 39.68 (+197.90% YoY)
Market capRs. 42,182.27 Cr
CMPRs. 1,596.90

Quarter Snapshot

Revenue grew 14.91% YoY with strong margin expansion (352 bps YoY) and significant deleveraging (debt/equity at 0.11). However, headline PAT is inflated by a one-time gain; normalized PAT grew 61.85% YoY. The Sintex/plastics segment loss deepened, and standalone business underperformed, warranting attention.

Key Investment Insights

Key Positives

  • Revenue grew 14.91% YoY to Rs.4,081.12 Cr.
  • Company Operating EBITDA Margin expanded 352 bps YoY to 19.73%, the highest in the available data window.
  • Normalized PAT (excluding one-time gain) grew 61.85% YoY to Rs.572.22 Cr.
  • Steel segment revenue grew 15.12% YoY to Rs.3,906.07 Cr, segment margin expanded 160 bps YoY to 15.33%.
  • Debt/Equity ratio fell to 0.11 from 0.23, interest coverage surged to 69.58x.
  • Networth grew 29.48% YoY to Rs.10,449.45 Cr.
  • Debtors days improved to 32 from 44 a year ago.

Risk Factors

  • Others segment (Sintex/plastics) loss widened to Rs.37.06 Cr from Rs.8.66 Cr YoY, with margin at -21.17%.
  • Standalone business underperformed: revenue declined 14.28% YoY, PAT fell 54.54% YoY, EBITDA margin compressed.
  • Depreciation and amortisation surged 46.95% YoY to Rs.124.58 Cr due to new plants, continuing to pressure earnings.
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now